These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31979298)

  • 1. Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy.
    Li S; Chen X; Chen H; Peng J; Yang X
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: A strategy for enhancing the therapeutic efficacy of chemotherapy.
    Amjadi S; Hamishehkar H; Ghorbani M
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():833-841. PubMed ID: 30678974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Peptide Amphiphile as a Drug Carrier with ATP-Triggered Release for Synergistic Effect, Improved Therapeutic Index, and Penetration of 3D Cancer Cell Spheroids.
    Lu S; Zhao F; Zhang Q; Chen P
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.
    Ramasamy T; Ruttala HB; Chitrapriya N; Poudal BK; Choi JY; Kim ST; Youn YS; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Jan; 48():131-143. PubMed ID: 27794477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
    Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
    Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
    Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhu LB; Xu WL; Zhang WW; Wu MC; Li WZ; Ge F; Tao YG; Song P
    Nanotechnology; 2021 Apr; 32(29):. PubMed ID: 33711826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
    Sun G; Sun K; Sun J
    Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy.
    Zhang P; Li J; Ghazwani M; Zhao W; Huang Y; Zhang X; Venkataramanan R; Li S
    Biomaterials; 2015 Oct; 67():104-14. PubMed ID: 26210177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycium barbarum polysaccharides grafted with doxorubicin: An efficient pH-responsive anticancer drug delivery system.
    Wang Y; Bai F; Luo Q; Wu M; Song G; Zhang H; Cao J; Wang Y
    Int J Biol Macromol; 2019 Jan; 121():964-970. PubMed ID: 30340000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BSA-based Cu
    Liu Z; Chan L; Ye X; Bai Y; Chen T
    Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release.
    Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.